Skip to main content
Clinical Trials/ACTRN12607000163404
ACTRN12607000163404
Not yet recruiting
Phase 2

A randomised controlled study to evaluate the effects of whey protein supplementation on bone structure, muscle mass, renal function, cardiovascular risk factors and body composition in elderly women

A Professor RL Prince0 sites220 target enrollmentMarch 9, 2007

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Bone structure of elderly healthy women
Sponsor
A Professor RL Prince
Enrollment
220
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 9, 2007
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
A Professor RL Prince

Eligibility Criteria

Inclusion Criteria

  • Able to comply with the requirements of the protocol.

Exclusion Criteria

  • Participation in another clinical trial during the last 12 weeks • Previous osteoporotic fracture• Currently or within last year taking medication for osteoporosis apart from calcium or vitamin D • Taking steroid tablets (eg Cortisone) in the past 3 months or have taken more than 7 g in total• Metabolic bone disease apart from osteoporosis• Total hip bone density more than 2SD below the mean for their age• Lactose intolerance or do not like milk products• High protein intake (more than 1\.5 g/kg body weight per day)• Cognitive impairment (Mini Mental Sate score \< 24\)• Body mass index \> 35 kg/cm2• Bowel surgery or difficulty absorbing food • Coeliac disease• Hepatic insufficiency or renal insufficiency • Participants who, in the opinion of the investigator are not likely to complete the study for any reason.

Outcomes

Primary Outcomes

Not specified

Similar Trials